Vertical Health Solutions, Inc. (OTCBB:VHSL)(OTCBB:VHSLW) today announced it has signed an exclusive licensing agreement with Belcher Pharmaceuticals, Inc., a wholly owned subsidiary of GeoPharma, Inc. (NASDAQ:GORX) for its animal version of sodium levothyroxine drug, used to treat thyroid-related conditions. Belcher Pharmaceuticals recently filed a patent on a novel method to stabilize the drug levothyroxine.
